• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • DeviceTalks Weekly
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Respicardia

Medicare might cover more cutting-edge medtech and pay more for it, too

July 30, 2019 By Nancy Crotti

The Centers for Medicare and Medicaid Services (CMS) said today it wants to give Medicare patients better access to cutting-edge medical devices, and that it’s willing to pay more for them beginning in fiscal year 2020. In its proposed rule, CMS said it might pay more for “certain transformative new devices” for inpatients through a […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Medicare, News Well, Regulatory/Compliance Tagged With: Boston Scientific, Centers for Medicare and Medicaid Services (CMS), CivaTech Oncology Inc., Claret Medical Inc., FDA, GT Medical Technologies, IsoRay, Johnson and Johnson, Procept BioRobotics, Respicardia, TherOx Inc, Zoll Medical

InVivo Therapeutics lifts Toselli to permanent prez, CEO | Personnel Moves February 6, 2018

February 6, 2018 By Fink Densford

InVivo Therapeutics (NSDQ:NVIV) said yesterday it made Dr. Richard Toselli’s spot in the corner office permanent, lifting him from acting CEO to prez and CEO. Dr. Toselli will maintain his position on the company’s board and as its chief medical officer, the position he was given when he joined the company last July. Prior to joining InVivo, […]

Filed Under: Business/Financial News Tagged With: Alcon, Baxter, Boston Scientific, Faxitron, GE Healthcare, InVivo Therapeutics, Johnson and Johnson, Lima Corporate, Luxottica, Medizone, Medtronic, performancehealth, Respicardia, Robocath, Sanofi-Aventis, T2 Biosystems Inc.

Respicardia launches Remedē system, taps Sommerness as CEO

February 2, 2018 By Fink Densford

Respicardia said today it launched its Remedē transvenous implantable neurostimulation system designed to treat patients with central sleep apnea, and that it named Peter Sommerness as CEO. The Remedē system consists of a surgically placed battery pack and thin wires inserted into the blood vessels in the chest near the phrenic nerve, which it stimulates to […]

Filed Under: Business/Financial News, Neuromodulation/Neurostimulation, Respiratory Tagged With: Respicardia

These medtech companies raised the most VC last year

January 19, 2018 By Danielle Kirsh

Perhaps there’s a ray of hope that venture capital funding is recovering a bit for the medical device industry. VC firms invested more than $2.8 billion in 2017, an increase of more than $647 million from 2016, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and CB Insights. There were a total 229 deals involving […]

Filed Under: Cardiovascular, Digital Health, Funding Roundup, Hospital Care, Implants Tagged With: Auris Surgical Robotics, Cereve, EarLens, Ebb Therapeutics, EBR Systems Inc., Epix Therapeutics (formerly Advanced Cardiac Therapeutics), Fractyl Laboratories, immusant, MedTech, Moximed, NeuroPace, Outset Medical, Pulmonx, Respicardia, rxsight, Silk Road Medical Inc., venture capital, VertiFlex Inc., Xenex

Zoll leads $59m Respicardia funding round

December 18, 2017 By Fink Densford

Respicardia said today it closed a $58.5 million financing round led by Zoll Medical to support commercialization efforts related to its Remede transvenous implantable neurostimulation system designed to treat patients with central sleep apnea. The Remedē system consists of a surgically placed battery pack and thin wires inserted into the blood vessels in the chest near the […]

Filed Under: Business/Financial News, Neuromodulation/Neurostimulation, Respiratory Tagged With: Respicardia, Zoll Medical

Respicardia wins FDA nod for Remedē central sleep apnea neurostim device

October 10, 2017 By Fink Densford

Respicardia said today that it won FDA approval for its Remedē transvenous implantable neurostimulation system designed to treat patients with central sleep apnea. Central Sleep Apnea occurs when the brain fails to control breathing during sleep, unlike the more common obstructive sleep apnea which consists of a partially collapsed airway which causes pauses in breathing, […]

Filed Under: Food & Drug Administration (FDA), Neuromodulation/Neurostimulation, Regulatory/Compliance, Respiratory Tagged With: Respicardia

Study: Respicardia neurostim implant shows promise in treating central sleep apnea

September 1, 2016 By Fink Densford

An implanted neurostimulator developed by Respicardia has been shown to significantly improve symptoms of central sleep apnea without serious side effects, according to a new study from the Ohio State University. Data from the study was presented at the European Society of Cardiology Congress in Rome and was published today in The Lancet. Central sleep […]

Filed Under: Clinical Trials, Implants, Neuromodulation/Neurostimulation, Respiratory Tagged With: Respicardia

Sorin drops $20m on stake in Respicardia

October 22, 2014 By Alexander Soule

Sorin drops $20m on stake in Respicardia

Sorin Group (BIT:SRN) said it invested $20 million in a minority stake and controlling option in Minnetonka, Minn.-based Respicardia, which is developing implantable devices to treat central sleep apnea.

Filed Under: Mergers & Acquisitions, News Well, Respiratory Tagged With: CE Mark, Respicardia, Sorin Group

1st patients enroll in Respicardia’s trial for sleep apnea implant

August 20, 2013 By Sony Salzman Leave a Comment

1st patients enroll in Respicardia's trial for sleep apnea implant

Minneapolis-based Respicardia said it launched a pivotal clinical trial of its Remede implantable device for central sleep apnea.

The pacemaker-like implant is designed to relieve sleep problems experienced by many heart failure and atrial fibrillation patients. It’s designed to send regular electrical impulses to the phrenic nerves, to prompt a response from the diaphragm.

Filed Under: Implants, News Well Tagged With: Clinical Trials, Respicardia, Sleep Monitoring/Sleep Apnea

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS